Courtney Turiano | Investor Relations |
Gregory Divis | Chief Executive Officer |
Tom McHugh | Chief Financial Officer |
Richard Kim | Chief Commercial Officer |
Jennifer Gudeman | Vice President of Medical and Clinical Affairs |
Christopher Howerton | Jefferies |
Francois Brisebois | Oppenheimer & Co. Inc. |
Ami Fadia | Needham & Co. |
Rudy Li | SVB Leerink |
David Amsellem | Piper Sandler & Co. |
Paul Matteis | Stifel |
Oren Livnat | H.C. Wainwright & Co. LLC |
Matthew Kaplan | Ladenburg Thalmann & Co. Inc. |
Robin Garner | Craig-Hallum Capital Group LLC |
Jason Gerberry | BofA Securities, Inc. |
Greetings and welcome to the Avadel Pharmaceuticals Third Quarter 2021 Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Courtney Turiano. Thank you.
You may begin.